Botulinum Toxin-Induced Parotitis: A Postoperative Complication Following Masseter Muscle Injection

J Oral Maxillofac Surg. 2024 May;82(5):525-530. doi: 10.1016/j.joms.2024.02.007. Epub 2024 Feb 16.

Abstract

Botulinum toxin (BTX) injection is a common treatment for bruxism, but there is no literature on potential salivary gland complications. This paper presents a case of acute parotitis in a 60-year-old female following BTX injections to the masseter muscle. This case highlights the possible salivary gland complications after injection of BTX into the masticatory muscles. An electronic search of PubMed and Embase databases was conducted to create a literature review in order to delve into the etiology behind the presented case and suggest potential preventive measures to avoid salivary gland complications. Thirty-one articles are reviewed and discussed. Currently, there is no consensus on the causes of the mentioned complication. However, various factors have been proposed, encompassing anatomical, physiological, biological, and physical aspects. Several methods have been recommended for the safe injection of BTX, which, along with better medical training and knowledge, are warranted to achieve predictable results.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Botulinum Toxins, Type A / administration & dosage
  • Botulinum Toxins, Type A / adverse effects
  • Botulinum Toxins, Type A / therapeutic use
  • Bruxism
  • Female
  • Humans
  • Injections, Intramuscular
  • Masseter Muscle*
  • Middle Aged
  • Neuromuscular Agents / administration & dosage
  • Neuromuscular Agents / adverse effects
  • Neuromuscular Agents / therapeutic use
  • Parotitis*
  • Postoperative Complications / prevention & control

Substances

  • Botulinum Toxins, Type A
  • Neuromuscular Agents